sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Veterinary Vaccines Market Scope And Analysis

  • Report Code : TIPRE00027165
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 134
Buy Now

Asia Pacific Veterinary Vaccines Market Analysis Report 2022 to 2028

Buy Now

Asia Pacific Veterinary Vaccines Market Report Asia Pacific Veterinary Vaccines Market Size and Share Asia Pacific Veterinary Vaccines Market Scope and Analysis

Asia Pacific Veterinary Vaccines Market Report Scope

Report Attribute Details
Market size in 2021 US$ 2,257.78 Million
Market Size by 2028 US$ 3,677.55 Million
Global CAGR (2021 - 2028) 7.2%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Vaccine Type
  • Livestock Vaccines
  • Companion Animal Vaccines
By Technology
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Conjugate Vaccines
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • BIOVAC
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Elanco
  • Hester Biosciences Limited
  • HIPRA
  • Merck Co Inc
  • NEOGEN Corporation
  • Virbac